Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.15
Bid: 17.80
Ask: 18.50
Change: -0.30 (-1.63%)
Spread: 0.70 (3.933%)
Open: 18.45
High: 0.00
Low: 0.00
Prev. Close: 18.45
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

18 May 2010 07:00

RNS Number : 0589M
BATM Advanced Communications Ld
18 May 2010
 



18 May 2010

 

BATM Advanced Communications Limited

Interim Management Statement

BATM Advanced Communications Limited ("BATM" or the "Company") (LSE: BVC), a leading designer and producer of Carrier Ethernet and Metropolitan Telecom Systems, is today issuing its Interim Management Statement for the period from 1 January 2010 to 30 April 2010.

Current trading update 

Total revenues in the first four months of 2010 were $ 36.0 million, compared with $38.9 million in the equivalent period in 2009. The decrease is due to a significant decline of revenues during the period from a major OEM channel in the Telecom division, as compared to those in the equivalent period in 2009. This has been somewhat offset by growth in other areas.

During these four months the sales mix was 63% from the Telecoms division and 37% from the Medical division. During April 2010, total revenues for the month were equal to those in April 2009, despite continuing weakness in the aforementioned OEM customer and substantial weakness in European economies.

The gross margin has decreased by 7% during the first four months of 2010 when compared to the same period in 2009, due to the change in the sales mix, caused by the reduced revenues from the major OEM customer. The gross margin in the Medical division has increased above the margin in 2009, a trend which we expect to continue.

Financial position 

The Company's balance sheet remains very strong and at the end of April the effective cash balance stood at $64.5 million, a decrease of $2.3 million compared to the position at 31 December 2009, largely due to erosion of Euro denominated balances. 

Board Developments

As reported in the Annual Report for 2009 both Ms Ariella Zochovitsky and Mr Koti Gavish will complete the second of their three year terms, the maximum term prescribed by Israeli law, in September 2010. In addition Dr. Dan Kaznelson has announced his decision to step down immediately prior to the forthcoming Annual General Meeting.

At the AGM the Board will be proposing the appointment of three new non-executives:

- Roger Lacey, Senior Vice President, Strategy and Planning, 3M with 11 years experience in the 3M Telecoms division;

- Professor Gideon Chitayat, currently Chairman of Delta Galil Industries and Honigman. Professor Chitayat has served as a director for Teva Pharmaceutical Industries and Bank Hapoalim among others; and

- Amos Shani, serial entrepreneur with experience in the Telecoms sector, former Division Engineering Manager for Intel, Israel.

Full resumes of the proposed new appointees will be made available ahead of the Annual General Meeting. The Board believes that these strong candidates will make an important contribution to the continued success of BATM.

Outlook Despite the disappointing start to the year, due almost exclusively to the low orders from our major OEM customer, from April onwards we have begun to see positive signs in our business. High customer activity in the US reported earlier in the year has started to convert into orders and we have signed two licensing agreements with new customers, including an agreement reported in April 2010 with a leading semi-conductor manufacturer, to license some of our mobile backhaul technology. Revenues from the licensing will begin in mid 2011 and are initially expected to be in the region of several US$ million. Management also sees positive prospects with important new customers.

Due to the substantial impact of the OEM customer decline coupled with the weakness of the Euro, we currently expect to be broadly break-even for the first six months. For the year as a whole, management are encouraged by the recent positive signs in the business, and remain cautiously optimistic that BATM will meet its revenue targets for the full year. The sales mix to date is expected to continue and management expects that the profitability in the second half of the year will be similar to that of the second half of 2009.

 

- ends -

 

Enquiries

 

BATM Advanced Communications +972 9866 2525

Dr Zvi Marom, Chief Executive

Threadneedle Communications 020 7653 9850

Josh Royston / Graham Herring

Singer Capital Markets Ltd 020 3205 7626 

Shaun Dobson

Shore Capital 020 7408 4090 

Pascal Keane

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDUGBBBGGR
Date   Source Headline
14th Apr 20229:30 amRNSAnnual Financial Report
13th Apr 20227:00 amRNSAppointment of Non-Executive Director
4th Apr 20227:00 amRNSTransaction in Own Shares and TVR
18th Mar 20227:00 amRNSStrategic Partnership for Edgility with NEXCOM
17th Mar 202210:30 amRNSResult of General Meeting
10th Mar 202212:30 pmRNSHolding(s) in Company
8th Mar 202211:30 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSFull Year Results
23rd Feb 20227:00 amRNSNotice of General Meeting
21st Feb 20227:00 amRNSStrategic Partnership for Edgility with Advantech
17th Feb 20227:00 amRNSTrading Update and Notice of Results
3rd Feb 202211:23 amRNSClarification on FTSE Nationality Review
3rd Feb 20227:00 amRNSUpdate on FTSE Nationality Review & Share Buyback
31st Jan 20227:00 amRNSUpdate on Ador Diagnostics
17th Jan 20227:00 amRNSUpdate on FTSE Nationality Review
4th Jan 20227:00 amRNSDividend Declaration
4th Jan 20227:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSFirst sales of rapid COVID-19 test in Russia
14th Dec 202111:45 amRNSResult of AGM and Dividend Declaration
30th Nov 20217:00 amRNSCOVID-19 tests effective in diagnosing Omicron
25th Nov 20213:00 pmRNSBlock Listing Interim Review
22nd Nov 20213:00 pmRNSNotice of AGM and Dividend Declaration
10th Nov 20217:00 amRNSBATM receives $3.5m cyber security contract
3rd Nov 20217:00 amRNSNew five-year contract for Edgility
1st Nov 20217:00 amRNSBATM receives agri-waste contract in Botswana
7th Oct 20217:00 amRNSStrategic partnership for NFV with AudioCodes
13th Sep 20217:00 amRNSFirst enterprise customer for NFV with $2m order
23rd Aug 20217:00 amRNSInterim Results
12th Aug 20217:00 amRNSNotice of Results
12th Jul 20217:00 amRNSLaunch of Edgility networking NFV-based ecosystem
5th Jul 20217:00 amRNSBATM receives $10m cyber security contract
15th Jun 20217:00 amRNSBATM receives $4.1m cyber security contract
26th May 20217:00 amRNSBlock listing Interim Review
18th May 20217:00 amRNSBATM commences delivery of new COVID-19 tests
19th Apr 202110:25 amRNSAnnual Financial Report
12th Apr 20217:00 amRNSStrategic partnership for NFV
29th Mar 20217:00 amRNSBATM develops molecular diagnostics test for TB
19th Mar 20217:00 amRNSCompletion of Sale of NGSoft
11th Mar 20217:00 amRNSBATM launches no-swab saliva-based COVID-19 test
1st Mar 20217:00 amRNSUpdate on Sale of NGSoft
22nd Feb 20217:00 amRNSFull Year Results
11th Feb 20215:38 pmRNSFTSE Nationality Review
1st Feb 20217:00 amRNSTrading Update and Notice of Results
19th Jan 20217:00 amRNSBATM's NFVTime now available for the public cloud
12th Jan 20217:00 amRNSBATM enters option agreement to sell NGSoft
24th Dec 20207:00 amRNSCOVID-19 test effective in diagnosing new strain
17th Dec 20203:50 pmRNSResult of AGM
15th Dec 20207:00 amRNSUpdate on Ador Diagnostics
7th Dec 20207:00 amRNSDelivery of First Insect Protein Recovery Facility
30th Nov 20203:03 pmRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.